达罗鲁米特 4

• CHMP建议欧盟批准达罗鲁米特加ADT用于mHSPC 2025/06/20
• CHMP recommends EU approval of darolutamide plus ADT in mHSPC 2025/06/20
• 不同mHSPC人群中剩余未满足的需求 2025/06/16
• Improving diversity in future clinical trials for mHSPC 2025/06/16